Overcoming sparseness of biomedical networks to identify drug repositioning candidates
Abstract
Modeling complex biological systems is necessary to understand biochemical interactions behind pharmacological effects of drugs. Successful in silico drug repurposing requires a thorough exploration of diverse biochemical concepts and their relationships, including drugs adverse reactions, drug targets, disease symptoms, as well as disease associated genes and their pathways, to name a few. We present a computational method for inferring drug-disease associations from complex but incomplete and biased biological networks. Our method employs the compressed sensing technique to overcome the sparseness of biomedical data and, in turn, to enrich the set of verified relationships between different biomedical entities. We present a strategy for identifying network paths supportive of drug efficacy as well as a computational procedure capable of combining different network patterns to better distinguish treatments from non-treatments. The data and programs are freely available at http://bioinfo.cs.uni.edu/AEONET.html.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 0.66
- Field percentile
- top 33%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug-disease networks and drug repurposing
Austin Polanco, Mark E. J. Newman·PLoS Computational BiologyPeer-reviewed·Oct 16, 2025
- Systematic integration of biomedical knowledge prioritizes drugs for repurposing
Daniel Himmelstein, Antoine Lizée, … Sergio E. Baranzini·eLifePeer-reviewed·Sep 22, 2017
- Disease networks and their contribution to disease understanding and drug repurposing: Evolution of the concept, techniques and data sources
Eduardo P. García del Valle, Gerardo Lagunes García, … Alejandro Rodríguez‐González·bioRxiv·May 6, 2019
- Uncovering new drug properties in target-based drug-drug similarity networks
Lucreția Udrescu, Paul Bogdan, … Mihai Udrescu·PharmaceuticsPeer-reviewed·Sep 16, 2020
- Drug2ways: Reasoning over causal paths in biological networks for drug discovery
Daniel Rivas-Barragan, Sarah Mubeen, … Daniel Domingo‐Fernándéz·PLoS Computational BiologyPeer-reviewed·Dec 2, 2020
- DREAM-GNN: Dual-route embedding-aware graph neural networks for drug repositioning
Yanlong Zhao, Yixiao Chen, … Can Chen·bioRxiv·Jul 7, 2025